We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$37.8B
AUM Growth
+$1.43B
Cap. Flow
+$830M
Cap. Flow %
2.19%
Top 10 Hldgs %
20.38%
Holding
4,005
New
290
Increased
1,922
Reduced
1,528
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 5.07%
3 Consumer Discretionary 3.53%
4 Communication Services 3.12%
5 Industrials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZENA
3776
ZenaTech Inc
ZENA
$169M
$33K ﹤0.01%
+10,198
New +$42.5K
CCO icon
3777
Clear Channel Outdoor Holdings
CCO
$1.23B
$32K ﹤0.01%
+14,649
New +$27.2K
PLG
3778
Platinum Group Metals
PLG
$196M
$32K ﹤0.01%
13,627
+1,000
+8% +$2.41K
LDI icon
3779
loanDepot
LDI
$298M
$29K ﹤0.01%
14,168
-5,811
-29% -$16.1K
CAN
3780
Canaan Creative
CAN
$154M
$28K ﹤0.01%
40,120
-19,431
-33% -$22.3K
SRFM icon
3781
Surf Air Mobility
SRFM
$98.2M
$28K ﹤0.01%
14,474
+2,924
+25% +$9.35K
AKBA icon
3782
Akebia Therapeutics
AKBA
$248M
$26K ﹤0.01%
15,909
-3,890
-20% -$8.14K
CLNE icon
3783
Clean Energy Fuels
CLNE
$384M
$25K ﹤0.01%
11,914
HYLN icon
3784
Hyliion Holdings
HYLN
$694M
$25K ﹤0.01%
13,621
+1,000
+8% +$2.01K
LXRX icon
3785
Lexicon Pharmaceuticals
LXRX
$1.05B
$25K ﹤0.01%
21,505
-1,895
-8% -$2.6K
SES icon
3786
SES AI
SES
$211M
$25K ﹤0.01%
+13,623
New +$30.5K
ASST icon
3787
Strive Inc
ASST
$1.06B
$24K ﹤0.01%
+1,653
New +$39.5K
CGC
3788
Canopy Growth
CGC
$431M
$24K ﹤0.01%
21,124
+2,381
+13% +$3.06K
WTI icon
3789
W&T Offshore
WTI
$555M
$20K ﹤0.01%
12,505
-210
-2% -$403
FLUX icon
3790
Flux Power
FLUX
$12.5M
$19K ﹤0.01%
15,000
-8,000
-35% -$23.6K
WPRT
3791
Westport Fuel Systems
WPRT
$34.6M
$19K ﹤0.01%
12,131
-500
-4% -$935
INTZ
3792
Intrusion
INTZ
$15M
$18K ﹤0.01%
15,560
-62
-0.4% -$98
TRIB
3793
Trinity Biotech
TRIB
$7.86M
$18K ﹤0.01%
743
CGEN icon
3794
Compugen
CGEN
$236M
$17K ﹤0.01%
11,250
BLNK icon
3795
Blink Charging
BLNK
$85.6M
$16K ﹤0.01%
24,702
+950
+4% +$1.37K
INVZ icon
3796
Innoviz Technologies
INVZ
$114M
$16K ﹤0.01%
+18,704
New +$29.6K
MAIA icon
3797
MAIA Biotechnology
MAIA
$83.9M
$16K ﹤0.01%
+10,620
New +$13.9K
PRPL icon
3798
Purple Innovation
PRPL
$28.4M
$14K ﹤0.01%
793
SGMO
3799
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14K ﹤0.01%
33,817
-973
-3% -$516
MVO
3800
DELISTED
MV Oil Trust
MVO
$13K ﹤0.01%
10,829
-20,575
-66% -$67.2K

Similar funds

Cambridge Investment Research Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Cambridge Investment Research Advisors held 4,005 positions worth $37.8B, up 3.9% from $36.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q4 2025 filing shows 290 new, 1,922 increased, 1,528 reduced and 192 closed positions. Its largest new stake was Akre Focus ETF: 1,072,509 shares worth $70.3M. The largest sale was Invesco NASDAQ 100 ETF, an estimated $85.8M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2025 buy was Akre Focus ETF: 1,072,509 shares worth $70.3M.
  • Cambridge Investment Research Advisors added most to Invesco Ultra Short Duration ETF in Q4 2025, an estimated $67M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2025 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $85.8M.
  • Cambridge Investment Research Advisors fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2025, selling an estimated $24.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $37.8B portfolio in Q4 2025.
  • Cambridge Investment Research Advisors opened 290 new positions and closed 192 in Q4 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 3.9% quarter-over-quarter to $37.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.